Document is current
Any future updates will be listed below
-
Authors
Nielsen, Janni
Pedersen, Jannik N.
Kleijwegt, Giulia
Nowak, Jan S.
Nami, Faranak
Johansen, Charlie
Sassetti, Elisa
Berg, Bjørn Bjerre
Lyngsø, Nanna Miang
Brøchner, Bo Volf
Carlson, Johanne Holm
Simonsen, Amanda
Olsen, William Pallisgaard
Simonsen, Bine Wissendorf
Mikkelsen, Jakob Hauge
Sereika-Bejder, Vita
Aarup Lauritsen, Johanne
Merrild, Kirstine Friis
Malle, Mette Galsgaard
Valero, Julián
Kjems, Jørgen
Bøggild, Andreas
Boesen, Thomas
Birkelund, Svend
Christiansen, Gunna
Hansen, Simon Boje
Kristensen, Marianne
Madsen, Peder Søndergaard
Strømgaard, Kristian
Romero-Ramos, Marina
Gustafsen, Camilla
Glerup, Simon
Andersen, Kasper Røjkjær
Clausen, Mads Hartvig
Otzen, Daniel E.
-
Funding
Funding for this research was provided by:
Danmarks Frie Forskningsfond (3103-00137B, 3103-00137B)
Lundbeck Foundation (R276-2018-671, R380-2021-1393, R346-2020-1999, R276-2018-671, R276-2018-671)
Danmarks Grundforskningsfond (DNRF135, DNRF135)
Novo Nordisk Fonden (NNF19OC0055818, NNF0086732)
Carlsbergfondet (CF19-0072, CF19-0337)
Uddannelses- og Forskningsministeriet (5072-00019B)
- License Information
-
More Information
Article History
Received: 22 November 2024
Accepted: 4 April 2025
First Online: 2 June 2025
Competing interests
: S.G., P.M., C.G., A.S., M.K. are all employees of Draupnir Bio, a biotech company with an interest in targeted protein degradation. Furthermore, Draupnir Bio has a pending patent application related to present study entitled “Bifunctional molecules that selectively induce degradation of extracellular targets in lysosomes” with the number WO2023247754A1. The remaining authors have no competing interests related to the present study.
